In a bid to expand its footprint and strengthen its position in the Indian market, ChemWerth has appointed Chandrakanth Reddy as General Sales Manager of its India office.

“The addition of a General Sales Manager in India signals our desire to grow our presence and customer base in the world’s most important generic pharmaceutical market. Chandrakanth will add tremendous value for our customers and Contract Manufacturing Organisations (CMOs) in India,” said Pete Werth III, President, ChemWerth.

Reddy is a seasoned pharmaceutical professional with over 16 years of experience spanning API sourcing, business development, market expansion and regulatory-driven commercial strategy. He has successfully led high-value markets across India, the Middle East, North Africa, Europe and the United States, building strong customer partnerships and supporting sustainable revenue growth.

In his new role, Reddy will be responsible for leading ChemWerth’s sales strategy in India and strengthening regional customer relationships. He will also support the company’s focused initiative to roll out new generic APIs in the market, including fermentation, peptide and oncology injectable APIs.

“After reviewing ChemWerth’s strategic plan to unveil a strong pipeline of new generic fermentation, peptide and oncology injectable APIs for the Indian market, I knew that was something I wanted to be a part of,” said Reddy.